Objective To capture the clinical patterns, timing of key milestones and survival of patients presenting with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) within Australia. Methods Data were prospectively collected and were timed to normal clinical assessments. An initial registration clinical report form (CRF) and subsequent ongoing assessment CRFs were submitted with a completion CRF at the time of death. Design Prospective observational cohort study. Participants 1834 patients with a diagnosis of ALS/MND were registered and followed in ALS/MND clinics between 2005 and 2015. Results 5 major clinical phenotypes were determined and included ALS bulbar onset, ALS cervical onset and ALS lumbar onset, flail arm ...
Background: Motor neuron diseases (MND) are rare yet severe neu-rodegenerative disorders with peculi...
International audience: Amyotrophic Lateral Sclerosis (ALS) is the most common motor neuron disease ...
To determine the average time from Amyotrophic Lateral Sclerosis (ALS) symptom onset to 11 pre-defin...
Background: Amyotrophic lateral sclerosis (ALS) is a progressive fatal disease with a varying range ...
The aim of our study was to analyse the natural history and clinical features of upper motor neuron-...
Background: Amyotrophic lateral sclerosis (ALS) is a progressive fatal disease with a varying range ...
Objective: To estimate amyotrophic lateral sclerosis (ALS) prevalence, 5-year survival, and explore ...
BACKGROUND: Despite the inevitability of disease progression in amyotrophic lateral sclerosis, there...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder that leads to destruction ...
Primary lateral sclerosis (PLS) is a neurodegenerative disease characterized by progressive upper mo...
Background:Amyotrophic lateral sclerosis (ALS) is a progressive fatal disease with a varying range o...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
International audienceObjectives were: i) to describe the phenotypic heterogeneity of incident amyot...
OBJECTIVE: To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify...
Background: Motor neuron diseases (MND) are rare yet severe neu-rodegenerative disorders with peculi...
International audience: Amyotrophic Lateral Sclerosis (ALS) is the most common motor neuron disease ...
To determine the average time from Amyotrophic Lateral Sclerosis (ALS) symptom onset to 11 pre-defin...
Background: Amyotrophic lateral sclerosis (ALS) is a progressive fatal disease with a varying range ...
The aim of our study was to analyse the natural history and clinical features of upper motor neuron-...
Background: Amyotrophic lateral sclerosis (ALS) is a progressive fatal disease with a varying range ...
Objective: To estimate amyotrophic lateral sclerosis (ALS) prevalence, 5-year survival, and explore ...
BACKGROUND: Despite the inevitability of disease progression in amyotrophic lateral sclerosis, there...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder that leads to destruction ...
Primary lateral sclerosis (PLS) is a neurodegenerative disease characterized by progressive upper mo...
Background:Amyotrophic lateral sclerosis (ALS) is a progressive fatal disease with a varying range o...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
International audienceObjectives were: i) to describe the phenotypic heterogeneity of incident amyot...
OBJECTIVE: To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify...
Background: Motor neuron diseases (MND) are rare yet severe neu-rodegenerative disorders with peculi...
International audience: Amyotrophic Lateral Sclerosis (ALS) is the most common motor neuron disease ...
To determine the average time from Amyotrophic Lateral Sclerosis (ALS) symptom onset to 11 pre-defin...